GENES GENERATION OF SARS-COV-2 FRAGMENT RBD MUTANTS AND ANTIBODY IDENTIFICATION TO PRODUCE AND MARKET REAGENTS NEEDED TO STUDY AND DETECT EARLY SPREAD OF THERAPEUTIC-RESISTANT MUTANTSshare on FacebookTwitterLinkedinEmailreport an issue